|
Q3 FY2026
As of Aug 31, 2026
|
Q2 FY2026
As of Jul 13, 2026
|
Q1 FY2026
As of Feb 28, 2026
|
Q4 FY2025
As of Nov 30, 2025
|
Q3 FY2025
As of Aug 31, 2025
|
Q2 FY2025
As of May 31, 2025
|
Q1 FY2025
As of Feb 28, 2025
|
|
|---|---|---|---|---|---|---|---|
| Cash | |||||||
| Short-term investment | |||||||
| Due from related party | |||||||
| Prepaid expenses | |||||||
| Total Current Assets | |||||||
| Deferred offering costs | |||||||
| Investments held in Trust Account | |||||||
| Total Assets | |||||||
| Accrued administrative expense | |||||||
| Accounts payable and accrued expenses | |||||||
| Due to target company (Eight Directions) | |||||||
| Promissory note - target company (Eight Directions) | |||||||
| Promissory note - related party | |||||||
| Due to related party | |||||||
| Total Current Liabilities | |||||||
| Deferred underwriting fee payable | |||||||
| Total Liabilities | |||||||
| Ordinary shares subject to possible redemption, 7,004,618 shares and 8,280,000 shares at redemption value of $10.65 and $10.29 per share as of August 31, 2026 and November 30, 2025, respectively | |||||||
| Ordinary shares, $0.0001 par value; 500,000,000 shares authorized; 3,129,900 shares issued and outstanding as of August 31, 2026 and November 30, 2025 (excluding 7,004,618 shares and 8,280,000 shares subject to possible redemption as of August 31, 2026 and November 30, 2025, respectively) | |||||||
| Additional paid-in capital | |||||||
| Accumulated deficit | |||||||
| Total Shareholders’ Deficit | |||||||
| Total Liabilities, Ordinary Shares Subject to Possible Redemption and Shareholders’ Deficit |
Loading...
